Older Mothers, Fertility Treatments Driving a Big Increase in Twin Births, New CDC Report Says
By Mike Stobbe,
Associated Press / The Washington Post
| 01. 04. 2012
ATLANTA — The number of twins born in the U.S. soared over the last three decades, mostly the result of test-tube babies and women waiting to have children until their 30s, when the chances of twins increase.
In 2009, 1 in every 30 babies born in the U.S. was a twin, an astounding increase over the 1 in 53 rate in 1980, according to a government report issued Wednesday.
“When people say it seems like you see more twins nowadays, they’re right,” said Joyce Martin, an epidemiologist who co-authored the Centers for Disease Control and Prevention report.
Some increase was expected as more women are delaying starting a family until they are over 30. For some unknown reason, mothers in their 30s are more likely to have twins than younger or older women. As much as a third of the increase can be attributed to that, Martin said.
The rest of the rise is due to fertility drugs and treatments.
“You have a double whammy going on. There are more older moms and more widespread use of fertility-enhancing therapies,” Martin...
Related Articles
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Hilary Bowman-Smart and Craig Stanbury, The Conversation | 06.12.2025
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...